Low prevalence of interleukin-6 haplotypes associated with a decreased risk of type 2 diabetes in Mexican subjects with a family history of type 2 diabetes.

Autor: Zamora-Ginez I; Facultad de Medicina, Benemérita Universidad Autónoma de Puebla (BUAP), Puebla, Mexico. Electronic address: zamoraginezi@yahoo.es., García-Zapién AG, Flores-Martínez SE, Sánchez-Corona J, Baez-Duarte BG, Torres-Rasgado E, Romero JR, Pérez-Fuentes R, Mendoza-Carrera F
Jazyk: angličtina
Zdroj: Archives of medical research [Arch Med Res] 2013 Oct; Vol. 44 (7), pp. 529-34. Date of Electronic Publication: 2013 Sep 17.
DOI: 10.1016/j.arcmed.2013.09.003
Abstrakt: Background and Aims: There is evidence that family history of type 2 diabetes (FHT2D) and single nucleotide polymorphisms (SNP) on the IL-6 gene promoter region are separately associated with the risk of developing type 2 diabetes. However the relationship between adult Mexican subjects with FHT2D and genotypes/haplotypes for IL-6 gene has not been explored. The aim of the present work was to study the prevalence of IL-6 -598G>A-572G>C-174G>C haplotypes among subjects with FHT2D and to determine whether their presence influences the relationship between FHT2D and risk factors for diabetes.
Methods: Two hundred fifty eight nondiabetic subjects participated in this study; 153 with and 105 without FHT2D. Polymerase chain reaction-restriction fragment-length polymorphism (PCR-RFLP) was used for genotyping. Logistic regression analysis was employed to assess the impact of IL-6 haplotypes on FHT2D per se and hyperinsulinemia and insulin resistance as risk factors for diabetes.
Results: Subjects with FHT2D showed a higher prevalence of hyperinsulinemia and insulin resistance (IR) than those without FHT2D (14.4 vs. 5.7%, p = 0.029, and 14.2 vs. 7.0% p = 0.050, respectively). Lower prevalence of -598 -572-174 (AGC)-haplotype (19%) in subjects with FHT2D was observed as well as a lower prevalence of hyperinsulinemia and IR among AGC haplotype carriers (12 and 14%, respectively). The relationship between FHT2D and IR was modified by the presence of AGC haplotype (from OR, 2.70; 95% CI, 0.99-7.36; p = 0.050 OR, 30.08; 95% CI, 0.58-1,568.06; p = 0.092).
Conclusions: IL-6 -598/-572/-174 (AGC) haplotype has a low prevalence among first-degree relatives of subjects with type 2 diabetes. Our results suggest that this haplotype is associated with decreased risk of type 2 diabetes in Mexican subjects with FHT2D.
(Copyright © 2013 IMSS. Published by Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: